Sirios Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-42,830
Closed -$3.08M 63
2024
Q3
$3.08M Sell
42,830
-113,236
-73% -$7.99M 0.55% 38
2024
Q2
$10.8M Buy
156,066
+105,598
+209% +$7.7M 1.88% 21
2024
Q1
$4.04M Buy
+50,468
New +$4.5M 0.76% 37
2015
Q3
Sell
-132,107
Closed -$7.7M 57
2015
Q2
$7.7M Sell
132,107
-21,736
-14% -$1.17M 0.25% 50
2015
Q1
$7.77M Buy
+153,843
New +$7.54M 0.29% 44

Other funds holding CNMD

Sirios Capital Management's CNMD Position: Q4 2024 in Review

Sirios Capital Management sold out of CONMED (CNMD) in Q4 2024, closing a stake of 42,830 shares — an estimated $3.08M sold.

Sirios Capital Management first reported a position in CNMD in Q1 2015 and held it in 5 quarters. The position peaked at $10.8M in Q2 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Sirios Capital Management reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Sirios Capital Management sold 42,830 CONMED shares in Q4 2024, an estimated $3.08M.
  • Sirios Capital Management first reported a position in CONMED in Q1 2015 and held it in 5 quarters.
  • Sirios Capital Management's CONMED position peaked at $10.8M in Q2 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Sirios Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.